News Daily News Surgical Aortic Valve Repair Effective, Durable in Experienced Hands Caitlin E. Cox December 21, 2017
News Daily News Isolated Tricuspid Valve Surgery Remains Rare and Risky Caitlin E. Cox December 13, 2017
News Daily News New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry Caitlin E. Cox November 30, 2017
News Conference News AHA 2017 More Support for TMVR After Failed Mitral Bioprostheses Yael L. Maxwell November 23, 2017
News Conference News TCT 2017 Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock Yael L. Maxwell November 09, 2017
News Conference News TCT 2017 TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG Ashley Lyles November 08, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
Presentation TCT 2017 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty Rings Presenter: Mayra Guerrero November 01, 2017
Presentation TCT 2017 TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial Presenter: Steven R. Bailey, Patrick W. Serruys, Nicolas M. Van Mieghem November 01, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Three Shelley Wood November 01, 2017
Presentation TCT 2017 Aortic Valve Replacement for CHF Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Howard C. Herrmann October 31, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
Presentation TCT 2017 Case #2: Double Aortic and Mitral Transcatheter Valve Replacement Using Innovative Bioprostheses Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Henrique B. Ribeiro October 31, 2017
Presentation TCT 2017 TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD October 31, 2017
Presentation TCT 2017 TCT 36: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement Presenter: Reginald I. Low, Michael J. Rinaldi, Richard Jabbour October 31, 2017
Presentation TCT 2017 TCT 52: Novel Preclinical Assessment of Transcatheter Mitral Valve Replacement by Micro-Computed Tomography: µCT Imaging-Guided Histopathological Evaluation Presenter: Peter C. Block, Lars Sondergaard, Armando Tellez, MD October 31, 2017
Presentation TCT 2017 TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger October 31, 2017
Presentation TCT 2017 TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe October 31, 2017
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD October 31, 2017